Magenta Therapeutics’ $69 Million Common Stock Offering

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the offering. Magenta Therapeutics, Inc. executed the $69 million follow-on offering…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now